Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TSH BiopharmROCO:8432 84 Dividend Yield % is 5.20% as of Jul. 15, 2026, which is 64% above its 10-year median of 3.17. GuruFocus rates ROCO:8432 with a GF Score™ of 84/100 and a GF Value™ of NT$78.92 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 515 Drug Manufacturers companies, TSH Biopharm ranks better than 89.71% on this metric.
As of today (2026-07-15), the Trailing Annual Dividend Yield of TSH Biopharm is 5.20%.
Good Sign:
TSH Biopharm Corp Ltd stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for TSH Biopharm's Dividend Yield % or its related term are showing as below:
ROCO:8432'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.9 Med: 3.17 Max: 8.37
Current: 5.2
During the past 13 years, the highest Dividend Yield of TSH Biopharm was 8.37%. The lowest was 1.90%. And the median was 3.17%.
ROCO:8432's Dividend Yield % is ranked better than 89.71% of 515
companies
in the Drug Manufacturers industry
Industry Median: 1.93
vs ROCO:8432: 5.20
During the past 12 months, TSH Biopharm's average Dividends Per Share Growth Rate was 65.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 12.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -0.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -3.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of TSH Biopharm was 133.10% per year. The lowest was -16.60% per year. And the median was -4.45% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for TSH Biopharm's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:8432 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TSH Biopharm Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where TSH Biopharm's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
TSH Biopharm Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 2.610000
2026-06-12
2026-06-15
2026-07-10
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
TSH Biopharm's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
2.61
/
50.20
=
5.20 %
Current Share Price is NT$50.20. TSH Biopharm's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$2.61.
TSH Biopharm's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
2.61
/
50.20
=
5.20 %
Current Share Price is NT$50.20. TSH Biopharm's Dividends per Share for the forward twelve months is calculated as NT$2.61 * 1 = NT$2.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSH Biopharm (ROCO:8432) has a Dividend Yield % of 5.20% as of Jul. 15, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on TSH Biopharm and its competitors. This is 64% above median its historical median of 3.17. Over the past decade, TSH Biopharm's Dividend Yield % has ranged from 1.90 to 8.37. According to the industry distribution chart, TSH Biopharm ranks #53 out of 515 companies in the Drug Manufacturers industry, placing it in the top 10.3%.
Is TSH Biopharm's Dividend Yield % too high?
TSH Biopharm's current Dividend Yield % of 5.20% is 64% above median its 10-year median of 3.17. Over the past 10 years, this metric has ranged from a low of 1.90 to a high of 8.37. The Drug Manufacturers industry median Dividend Yield % is 1.93. TSH Biopharm's value of 5.20% is 169.4% above this industry median. Based on the distribution chart, TSH Biopharm ranks #53 out of 515 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, TSH Biopharm has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TSH Biopharm's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, TSH Biopharm ranks #53 out of 515 companies for Dividend Yield %. This places TSH Biopharm in the top 10% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.93. TSH Biopharm's value of 5.20% is 169.4% above this benchmark. Historically, TSH Biopharm's own Dividend Yield % has ranged from 1.90 to 8.37 over the past decade. While the company's 10-year median is 3.17 vs. the industry median of 1.93, TSH Biopharm has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.93, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TSH Biopharm's current Dividend Yield % of 5.20% is 169.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on TSH Biopharm and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TSH Biopharm's current Dividend Yield % is 5.20%, which is 64% above median its own 10-year median of 3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TSH Biopharm stock overvalued right now?
Based on GuruFocus' analysis, TSH Biopharm (ROCO:8432) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$78.92, compared to a current price of NT$50.20 — trading 36.4% below its estimated fair value. The current Dividend Yield % is 5.20%, which is 64% above median its 10-year median of 3.17 and 169.4% above the Drug Manufacturers industry median of 1.93. TSH Biopharm's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For TSH Biopharm (ROCO:8432), the current Dividend Yield % is 5.20% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TSH Biopharm (ROCO:8432) Overvalued in 2026?
Based on GuruFocus' analysis, TSH Biopharm stock appears to be undervalued.
The current stock price of NT$50.20 is trading 36.4% below its estimated GF Value™ of NT$78.92.
GuruFocus considers TSH Biopharm to be Significantly Undervalued.
Key valuation signals for ROCO:8432:
Dividend Yield %: 5.20% (64% above median its 10-year median of 3.17)
GF Value™: NT$78.92 vs. price of NT$50.20 (36.4% below fair value)
Industry Position: 169.4% above the Drug Manufacturers median (#53 of 515)
No single metric tells the full story. See the ROCO:8432 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TSH Biopharm Corp Ltd is engaged in sale of a variety of pharmaceuticals, chemical drugs and engaged in biotechnology services. The company specializes in the development, manufacture, and marketing of branded drugs for chronic diseases. Key therapeutic areas include cardiovascular, central nervous system, gastroenterology, and severe chronic diseases, alongside precision medicine/genetic testing services .The Company's revenue is earned domestically. It earns majority of its revenue from the sale of Lozenges.
84GF Score
Get the complete analysis for ROCO:8432
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8432 has been successfully added to your 
